Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

23 Nov 2017 07:00

RNS Number : 2712X
Bunzl PLC
23 November 2017
 

23 November 2017

 

 

BUNZL COMPLETES ACQUISTION IN FRANCE AND ANNOUNCES FURTHER EXPANSION IN AUSTRALIA AND BRAZIL

 

Bunzl plc, the international distribution and outsourcing Group, today announces that the acquisition of Hedis, Comptoir de Bretagne and Générale Collectivités, that was announced on 20 July 2017, has been completed following clearance of the transaction by the French Competition Authority.

 

The Company has also recently acquired Interpath in Australia and entered into an agreement to acquire Talge in Brazil.

 

Interpath, which is based in Melbourne, is principally engaged in the distribution of a variety of laboratory and healthcare related consumable products to the pathology, medical research and life science end user markets in Australia. Customers include public and private hospitals and other pathology and research laboratories. Revenue in the year ended June 2017 was A$22 million (c.£13 million).

 

Talge, which is based in Santa Catarina, is principally engaged in the sale of a variety of foodservice related products, mainly to redistributors in the southeast region of Brazil. Revenue in the year ended December 2016 was R$83 million (c.£20 million). Completion of the acquisition is subject to clearance of the transaction by the Brazilian competition authority.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"I am delighted that we have now completed the purchase of Hedis, Comptoir de Bretagne and Générale Collectivités. Together these businesses further expand our existing cleaning & hygiene operations in France and extend our business there into the catering equipment sector for the first time.

 

The acquisition of Interpath has enhanced our healthcare business in Australia and extended our product offering into the pathology, medical research and life science markets there, while the proposed purchase of Talge will expand our operations into the foodservice sector in Brazil."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBATMBTTBTR
Date   Source Headline
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20258:00 amRNSAdditional Listing
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20254:06 pmRNSAnnual Financial Report
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20255:40 pmRNSIssue of Debt
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20255:05 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20255:07 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20255:25 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 202511:22 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202511:28 amRNSTotal Voting Rights
3rd Mar 202510:00 amRNSDividend Declaration
3rd Mar 20257:01 amRNS2025 Share Buyback Programme - Update
3rd Mar 20257:00 amRNSFinal Results
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20252:58 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:26 pmRNSDirector/PDMR Shareholding
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20255:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.